Meckler Jeffrey A bought INDP
February 11, 2026 · Form 4 insider transaction
Meckler Jeffrey A bought 1,519 shares of Indaptus Therapeutics, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,519
Price
N/A
Total value
N/A
InsiderMeckler Jeffrey A
RoleDirector
SecurityWarrants (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 11, 2026
Filing dateFebruary 13, 2026
Shares owned after1,519
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Effective February 11, 2026, the Board of Directors of the Company approved a unilateral reduction in the per share exercise price of the warrants to $1.75. All of the other terms of the warrants remained unchanged.